Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
N-Butyl-deoxynojirimycin (NB-DNJ) has been approved for clinical trials as a potential therapy for Gaucher disease, a glycolipid lysosomal storage disorder. As this compound has both glycoprotein processing α-glucosidase and ceramide glucosyltransferase inhibitory activity, we have sought to determi...
मुख्य लेखकों: | Butters, T, van den Broek, L, Fleet, G, Krulle, T, Wormald, M, Dwek, R, Platt, F |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2000
|
समान संसाधन
-
Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.
द्वारा: Boomkamp, S, और अन्य
प्रकाशित: (2010) -
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
द्वारा: Mellor, H, और अन्य
प्रकाशित: (2003) -
Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2000) -
Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2005) -
Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.
द्वारा: van der Spoel, A, और अन्य
प्रकाशित: (2008)